Atlas Trials

Nicotinamide Riboside for Diabetic Neuropathy

Clinical trial NCT03685253 · TERMINATED

Trial details

NCT number
NCT03685253
Sponsor
University of Maryland, Baltimore
Status
TERMINATED
Phase
Phase 1, Phase 2
Study type
INTERVENTIONAL
Diabetic Neuropathy Peripheral
Start date
2019-01-24
Primary completion
2022-05-01
Enrollment
10

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.